These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8672634)

  • 21. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems.
    Alonso MJ; Gupta RK; Min C; Siber GR; Langer R
    Vaccine; 1994 Mar; 12(4):299-306. PubMed ID: 8178550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromatographic studies of mitomycin C degradation in albumin microspheres.
    Mehta RC; Hogan TF; Mardmomen S; Ma JK
    J Chromatogr; 1988 Sep; 430(2):341-9. PubMed ID: 3148622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro biodegradation of polyhydroxybutyrate-hydroxyvalerate microcapsules exposed to Hank's buffer, newborn calf serum, pancreatin and synthetic gastric juice.
    Atkins TW; Peacock SJ
    J Microencapsul; 1997; 14(1):35-49. PubMed ID: 8994074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intestinal enzymatic metabolism of drugs.
    Sarti F; Barthelmes J; Iqbal J; Hintzen F; Bernkop-Schnürch A
    J Pharm Pharmacol; 2011 Mar; 63(3):392-9. PubMed ID: 21749387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo degradation and biocompatibility study of in vitro pre-degraded as-polymerized polyactide particles.
    Bergsma JE; Rozema FR; Bos RR; Boering G; de Bruijn WC; Pennings AJ
    Biomaterials; 1995 Mar; 16(4):267-74. PubMed ID: 7772665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biodegradable poly(DL-lactic acid) formulations in a calcitonin delivery system.
    Asano M; Yoshida M; Omichi H; Mashimo T; Okabe K; Yuasa H; Yamanaka H; Morimoto S; Sakakibara H
    Biomaterials; 1993 Aug; 14(10):797-9. PubMed ID: 8218732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Preparation and toxicity of triptolide-loaded poly (D,L-lactic acid) nanoparticles].
    Liu MX; Dong J; Yang YJ; Yang XL; Xu HB
    Yao Xue Xue Bao; 2004 Jul; 39(7):556-60. PubMed ID: 15493850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flavan-3-ol C-glycosides--preparation and model experiments mimicking their human intestinal transit.
    Hasslauer I; Oehme A; Locher S; Valotis A; Van't Slot G; Humpf HU; Schreier P
    Mol Nutr Food Res; 2010 Nov; 54(11):1546-55. PubMed ID: 20468005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of H+ liberated from hydrolytic cleavage of polyester microcapsules on their permeability and degradability.
    Sah H; Chien YW
    J Pharm Sci; 1995 Nov; 84(11):1353-9. PubMed ID: 8587055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation and characterization of poly-(D,L-lactide-co-glycolide) and poly-(L-lactic acid) microspheres with entrapped pneumotropic bacterial antigens.
    Kofler N; Ruedl C; Klima J; Recheis H; Böck G; Wick G; Wolf H
    J Immunol Methods; 1996 Jun; 192(1-2):25-35. PubMed ID: 8699019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biodegradation of poly(ethylene adipate) microcapsules in physiological media.
    Atkins TW
    Biomaterials; 1998; 19(1-3):61-7. PubMed ID: 9678851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Degradation of poly(lactic-co-glycolic acid) microspheres: effect of copolymer composition.
    Park TG
    Biomaterials; 1995 Oct; 16(15):1123-30. PubMed ID: 8562787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poly(lactic acid) nanoparticles coated with combined WGA and water-soluble chitosan for mucosal delivery of β-galactosidase.
    Sheng Y; He H; Zou H
    Drug Deliv; 2014 Aug; 21(5):370-8. PubMed ID: 24797098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microencapsulation using poly(L-lactic acid) IV: Release properties of microcapsules containing phenobarbitone.
    Jalil R; Nixon JR
    J Microencapsul; 1990; 7(1):53-66. PubMed ID: 2308054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of polymer degradation in implantable devices. 2. Poly(DL-lactic acid).
    Ali SA; Doherty PJ; Williams DF
    J Biomed Mater Res; 1993 Nov; 27(11):1409-18. PubMed ID: 8263003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PEG-coated poly(lactic acid) nanoparticles for the delivery of hexadecafluoro zinc phthalocyanine to EMT-6 mouse mammary tumours.
    Allémann E; Brasseur N; Benrezzak O; Rousseau J; Kudrevich SV; Boyle RW; Leroux JC; Gurny R; Van Lier JE
    J Pharm Pharmacol; 1995 May; 47(5):382-7. PubMed ID: 7494187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enzymatic activity toward poly(L-lactic acid) implants.
    Schakenraad JM; Hardonk MJ; Feijen J; Molenaar I; Nieuwenhuis P
    J Biomed Mater Res; 1990 May; 24(5):529-45. PubMed ID: 2324125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Intravitreal drug delivery by microspheres of biodegradable polymers].
    Moritera T; Ogura Y; Honda Y; Wada R; Hyon SH; Ikada Y
    Nippon Ganka Gakkai Zasshi; 1990 May; 94(5):508-13. PubMed ID: 2220493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of plasma glow, glutaraldehyde and carbodiimide treatments on the enzymic degradation of poly (L-lactic acid) and poly (gamma-benzyl-L-glutamate) films.
    Chandy T; Sharma CP
    Biomaterials; 1991 Sep; 12(7):677-82. PubMed ID: 1720676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanostructured hydroxyapatite/poly(lactic-co-glycolic acid) composite coating for controlling magnesium degradation in simulated body fluid.
    Johnson I; Akari K; Liu H
    Nanotechnology; 2013 Sep; 24(37):375103. PubMed ID: 23975041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.